Cargando…

Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response

With the introduction of pertussis immunization for pregnant women in many countries, there has been renewed interest in the impact of whole-cell pertussis vaccine (wP) versus acellular vaccine (aP) on disease control, particularly regarding the best approach for priming. To gather evidence on this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin Aispuro, Pablo, Bottero, Daniela, Zurita, María Eugenia, Gaillard, María Emilia, Hozbor, Daniela Flavia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10330814/ https://www.ncbi.nlm.nih.gov/pubmed/37435078 http://dx.doi.org/10.3389/fimmu.2023.1192119

Ejemplares similares

Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency
por: Gaillard, María Emilia, et al.
Publicado: (2017)

Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life
por: Martin Aispuro, Pablo, et al.
Publicado: (2020)

Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture
por: Carriquiriborde, Francisco, et al.
Publicado: (2021)

Outer-Membrane-Vesicle–Associated O Antigen, a Crucial Component for Protecting Against Bordetella parapertussis Infection
por: Bottero, Daniela, et al.
Publicado: (2018)

Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity
por: Szwejser-Zawislak, Ewa, et al.
Publicado: (2022)

Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern
por: Rudi, Erika, et al.
Publicado: (2022)

Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron
por: Bottero, Daniela, et al.
Publicado: (2023)

Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina
por: Carriquiriborde, Francisco, et al.
Publicado: (2019)

Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles
por: van der Lee, Saskia, et al.
Publicado: (2018)

Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice
por: Weaver, Kelly L., et al.
Publicado: (2022)

Bordetella pertussis Whole Cell Immunization, Unlike Acellular Immunization, Mimics Naïve Infection by Driving Hematopoietic Stem and Progenitor Cell Expansion in Mice
por: Varney, Melinda E., et al.
Publicado: (2018)

Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against Bordetella pertussis in a Mouse Model
por: Jiang, Wenwen, et al.
Publicado: (2022)

Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring
por: Dubois, Violaine, et al.
Publicado: (2023)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
por: Esposito, Susanna, et al.
Publicado: (2019)

Immunization with the Recombinant Cholera Toxin B Fused to Fimbria 2 Protein Protects against Bordetella pertussis Infection
por: Olivera, Noelia, et al.
Publicado: (2014)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
por: van der Lee, Saskia, et al.
Publicado: (2018)

Maternal vaccination: shaping the neonatal response to pertussis
por: Callender, Maiya, et al.
Publicado: (2023)

Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice
por: Wolf, M. Allison, et al.
Publicado: (2021)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Novel murine model reveals an early role for pertussis toxin in disrupting neonatal immunity to Bordetella pertussis
por: Sedney, Colleen J., et al.
Publicado: (2023)

A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains
por: Zurita, María Eugenia, et al.
Publicado: (2019)

The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-Analysis
por: Abu-Raya, Bahaa, et al.
Publicado: (2021)

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
por: Boehm, Dylan T., et al.
Publicado: (2019)

Immunization with whole cell but not acellular pertussis vaccines primes CD4 T(RM) cells that sustain protective immunity against nasal colonization with Bordetella pertussis
por: Wilk, Mieszko M., et al.
Publicado: (2019)

What Pertussis Mortality Rates Make Maternal Acellular Pertussis Immunization Cost-Effective in Low- and Middle-Income Countries? A Decision Analysis
por: Russell, Louise B., et al.
Publicado: (2016)

Proteomics of Bordetella pertussis whole-cell and acellular vaccines
por: Möller, Jens, et al.
Publicado: (2019)

Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy
por: Alghounaim, Mohammad, et al.
Publicado: (2022)

Immunological Distinctions between Acellular and Whole-Cell Pertussis Immunizations of Baboons Persist for at Least One Year after Acellular Vaccine Boosting
por: Cole, Leah E., et al.
Publicado: (2020)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Canonical and Non-canonical Inflammasome Activation by Outer Membrane Vesicles Derived From Bordetella pertussis
por: Elizagaray, Maia L., et al.
Publicado: (2020)

The Role of Mucosal Immunity in Pertussis
por: Solans, Luis, et al.
Publicado: (2019)

Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization
por: Acquaye-Seedah, Edith, et al.
Publicado: (2018)

Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative
por: Feng, Ye, et al.
Publicado: (2021)

OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule
por: Perez Chacon, Gladymar, et al.
Publicado: (2020)

Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation
por: Auderset, Floriane, et al.
Publicado: (2019)

1483. Maternal Tdap Vaccination During Pregnancy and Immune Response: A Comparison Between Infants Born to Mothers Primed with Acellular or Whole Cell Pertussis Vaccines
por: Havers, Fiona, et al.
Publicado: (2020)

Modeling the cost-effectiveness of maternal acellular pertussis immunization (aP) in different socioeconomic settings: A dynamic transmission model of pertussis in three Brazilian states
por: Luz, Paula M., et al.
Publicado: (2021)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

Choosing from Whole Cell and Acellular Pertussis Vaccines-Dilemma for the Developing Countries
por: SYED, Muhammad Ali
Publicado: (2017)

Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants
por: Knuutila, Aapo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8liib1riarah10p5qlqs7vpb67